Product Images Levetiracetam
View Photos of Packaging, Labels & Appearance
- Recommended Dosage Adjustment Formula - levetiracetam 1
- Figure 3 - levetiracetam 10
- Figure 4 - levetiracetam 11
- Figure 5 - levetiracetam 12
- Imprint Marking - levetiracetam 13
- Carton 250 - levetiracetam 14
- Recommended Dosage Adjustment Formula - levetiracetam 2
- Imprint Marking - levetiracetam 3
- Imprint Marking - levetiracetam 4
- Imprint Marking - levetiracetam 5
- Imprint Marking - levetiracetam 6
- Chemical Structure - levetiracetam 7
- Figure 1 - levetiracetam 8
- Figure 2 - levetiracetam 9
Product Label Images
The following 14 images provide visual information about the product associated with Levetiracetam NDC 66993-100 by Prasco Laboratories, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Recommended Dosage Adjustment Formula - levetiracetam 1
This text provides formulas for estimating the glomerular filtration rate (GFR) in adults based on age, weight, gender, and serum creatinine levels. It uses age, weight, and serum creatinine as variables to calculate GFR. The formula adjusts for gender by multiplying by 0.85 for female patients.*
Figure 3 - levetiracetam 10
Percentage distribution of participants receiving placebo and Levetiracetam at a dosage of 3000mg/day: Placebo - 39.4%, Levetiracetam - 14.4%. 104 participants received placebo, while 180 participants received Levetiracetam at the specified dosage.*
Figure 4 - levetiracetam 11
Figure 5 - levetiracetam 12
This data table provides the percentage of patients in two groups, Placebo (N=84) and Levetiracetam (N=79), with values ranging from 0% to 100%. The percentage of patients is shown alongside the corresponding percentage values from 0% to 100%.*
Imprint Marking - levetiracetam 13
Carton 250 - levetiracetam 14
This text appears to be a set of instructions for a medication product called Levetiracetam, which comes in the form of tablets for oral suspension. It specifies the content of each tablet and provides guidance on administration. The product seems to be intended for institutional use based on the provided information.*
Recommended Dosage Adjustment Formula - levetiracetam 2
Imprint Marking - levetiracetam 3
Imprint Marking - levetiracetam 4
Imprint Marking - levetiracetam 5
Imprint Marking - levetiracetam 6
Chemical Structure - levetiracetam 7
Figure 1 - levetiracetam 8
This text represents a visualization of the percentage of patients in different treatment groups, including placebo and different doses of Levetiracetam. The data is shown in a bar graph format with varying percentages for each group. The total number of patients in each group is also provided.*
Figure 2 - levetiracetam 9
This appears to be a description related to a study or experiment involving different dosages of Levetiracetam and a placebo. The text includes percentages indicating different dosages and sample sizes for each group treated with Levetiracetam at 1000mg/day and 2000mg/day, as well as the placebo group. The data seems to be organized for comparison or analysis purposes.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
